• Big Data for Breast Cancer (BD4BC)

    MAP

    Komen envisions a world in which healthcare is a seamless web of information: patients are informed about their data and are empowered to share it and participate in their health care, data systems are linked and easily accessible, genomics (and other –omics) are universally available and user-friendly, and electronic health records (EHR) are connected to other sources of data to provide evidence-based support for the generation of research hypotheses and clinical decision-making.

    Overview


    With the insights gained at our BD4BC meetings and the guidance of our Scientific Advisory Board, we have identified key roles for Komen and specific big data programs that will drive the field forward. Our Big Data for Breast Cancer Initiative aims at using big data to fuel scientific discoveries and accelerate the delivery of equitable, patient-focused care. It takes a three-pronged approach to:

    1. Empower the public with information and tools to make data sharing understandable and easy to do.
    2. Address challenges of incorporating big data applications into breast cancer research and clinical care.
    3. Fund data science projects to improve breast cancer outcomes and save lives.

    BD4BC Meetings


    Realizing that big data holds great promise for advancing research and improving breast cancer patient care and outcomes, we started the big data for breast cancer conversation in 2015 by convening more than 130 experts representing approximately 100 organizations, both non- and for-profit, to explore the opportunities and challenges of incorporating big data applications into breast oncology research and clinical care.

    Since then, we have continued to drive the discussion, and through our convening power we have catalyzed data science collaborations focused on breast cancer in efforts to drive progress toward our Bold Goal of reducing the current number of breast cancer deaths by 50% in the U.S. by 2026.

    In order to move toward the improvement of cancer research and clinical care through data integration and utilization, Komen convened three Big Data meetings:

    1. BD4BC Meeting in New York City, NY; October 8-9, 2015.
    2. BD4BC\WC in Menlo Park, CA; February 23-24, 2017.
    3. BD4BC3 in Menlo Park, CA; February 1-2, 2018.

    Sponsors & Supporters


    Without the sponsors and supporters of our Big Data for Breast Cancer (BD4BC) initiative, we'd never be able to do what we do – empower the public with information and tools to make data sharing understandable and easy to do, address challenges of incorporating big data applications into breast cancer research and clinical care and fund data science projects to improve breast cancer outcomes and save lives. Their generosity and tireless efforts allow us to continue striving to save lives and end breast cancer forever.

    Susan G. Komen BD4BC Initiative – Founding Member

    Robertson Foundation Logo

    With supporting the first two BD4BC meetings, the Robertson Foundation partnered with Susan G. Komen in starting the conversation highlighting the opportunities and challenges of incorporating big data applications into oncology research and clinical care.

    Susan G. Komen BD4BC Initiative – Patient Education Programs Sponsor

    Pfizer Logo

    As a sponsor of the patient education programs of Susan G. Komen’s Big Data for Breast Cancer Initiative, Pfizer joins Komen to advance our mutual goal of accelerating research by ensuring patients have the information and tools needed to make data sharing understandable and easy to do.


  • Questions?

    Send us a message